Instrument number PB 96 of 2008
Amendment special arrangements under subsection 100(1) of the National Health Act 1953
I, DIANA MACDONELL, Acting Assistant Secretary, Pharmaceutical Evaluation Branch, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this instrument under subsection 100(1) of the National Health Act 1953.
Dated 1st SEPTEMBER 2008
DIANA MACDONELL
Acting Assistant Secretary
Pharmaceutical Evaluation Branch
Department of Health and Ageing
Amendment Special Arrangements — Chemotherapy Pharmaceuticals Access Program
1 Commencement
This instrument commences on 1 October 2008.
2 Amendment of PB 82 of 2008
Schedule 1 amends PB 82 of 2008.
Schedule 1 Amendments
[1] Subparagraph 4(b)
omit:
2(f)
and substitute:
2(g)
[2] Paragraph 12
omit:
Schedule 7
and substitute:
Schedule 3
[3] Schedule 2, item dealing with Cisplatin in the form I.V. injection
100 mg in 100 mL
insert in the column headed “Brand” in alphabetical order:
Pfizer Australia Pty Ltd